KFDA publishes new guideline for bridging study

The Korea Food and Drug Administration says it has formulated a new guideline aiming to assess foreign bridging studies in Korea.

The guideline covers the submission scope of bridging study data related to the approval of new drugs, including detailed instruction and descriptions on bridging study,

Bridging study is aimed at providing pharmacodynamic or clinical data on efficacy, safety, ...